An Ultra-miniaturized Inflammation Monitoring Platform Implemented by Long Afterglow Lat-eral Flow Immunoassay

Jiuchuan Guo,Yiming Zhang,Yusheng Fu,Jinhong Guo,Diangeng Li

DOI: https://doi.org/10.1109/jsen.2024.3458995

IF: 4.3

2024-01-01

IEEE Sensors Journal

Abstract:Abnormal fluctuations of inflammatory factors may reflect the immune response and pathological pro-cesses of the body. The real-time monitoring of these indicators is critical for the treatment and prognosis of infectious or autoimmune diseases. Among numerous point-of-care testing methods, lateral flow immunoassay (LFIA) has a high impact due to its unique superiority in convenience and rapidity. However, traditional colloidal gold based LFIAs suffer from qualitative or semi-quantitative detection, while most of the optical nanoprobes enabled quantitative LFIAs re-quire expensive equipment for signal reading, not benefiting widespread needs for personal or home use. To confront these challenges, in this work, we propose a new generation of LFIA by using ultra-long afterglow nanoprobes (UANPs) and a self-developed miniaturized sensing device for simultaneous detection of C-reactive protein (CRP) and serum amyloid A (SAA). Hydrophilic and surface-modified UANPs are prepared in uniform size and good dispersibility by a two-step method. The afterglow sensing strategy effectively avoids biological endogenous background and excitation light interference. We therefore develop an ultra-miniaturized low-cost device with conventional optical components, omitting complicated filtering modules. As a result, the UANP-LFIA achieved detection linear ranges of 0.7~250 ng/mL for CRP and 1~200 ng/mL for SAA, with detection limits of 0.67 ng/mL and 0.81 ng/mL, respectively. Moreover, the palm-size sensing device can be interconnected with smart terminals and is capable of uploading medical data, providing a more accurate strategy for identifying infection types and assessing disease severity.